PortfoliosLab logoPortfoliosLab logo
ResMed Inc. (RMD)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US7611521078
CUSIP
761152107
IPO Date
Jun 2, 1995

Highlights

EPS (TTM)
$15.16
PE Ratio
14.81
PEG Ratio
0.46
Total Revenue (TTM)
$5.40B
Gross Profit (TTM)
$3.29B
EBITDA (TTM)
$1.96B
Year Range
$199.92 - $293.81
Target Price
$294.00
ROA (TTM)
17.47%
ROE (TTM)
23.51%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in ResMed Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

ResMed Inc. (RMD) has returned -6.59% so far this year and 1.18% over the past 12 months. Looking at the last ten years, RMD has achieved an annualized return of 15.62%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.


ResMed Inc.

1D
2.02%
1M
-12.40%
YTD
-6.59%
6M
-17.61%
1Y
1.18%
3Y*
1.78%
5Y*
3.81%
10Y*
15.62%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jun 2, 1995, RMD's average daily return is +0.11%, while the average monthly return is +2.17%. At this rate, your investment would double in approximately 2.7 years.

Historically, 61% of months were positive and 39% were negative. The best month was Feb 2000 with a return of +73.5%, while the worst month was Feb 1999 at -37.1%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 4 months.

On a daily basis, RMD closed higher 51% of trading days. The best single day was Apr 14, 1999 with a return of +27.4%, while the worst single day was May 3, 2000 at -22.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20267.24%-0.56%-12.40%-6.59%
20253.28%-0.90%-4.14%5.69%3.69%5.40%5.40%1.16%-0.28%-9.81%3.87%-5.85%6.26%
202410.57%-8.43%13.99%8.06%-3.37%-7.23%11.40%15.17%-0.37%-0.68%2.92%-8.16%34.18%
20239.72%-6.55%2.81%10.03%-12.35%3.66%1.76%-28.04%-7.34%-4.50%12.05%9.06%-16.55%
2022-12.24%8.13%-1.72%-17.54%1.96%3.03%14.74%-8.39%-0.74%2.47%3.12%-9.59%-19.47%
2021-5.17%-4.17%0.64%-3.12%9.73%19.76%10.25%7.05%-9.29%-0.24%-2.91%2.21%23.41%

Benchmark Metrics

ResMed Inc. has an annualized alpha of 21.67%, beta of 0.80, and R² of 0.14 versus S&P 500 Index. Calculated based on daily prices since June 05, 1995.

  • This stock captured 132.53% of S&P 500 Index gains but only 74.95% of its losses — a favorable profile for investors.
  • R² of 0.14 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
21.67%
Beta
0.80
0.14
Upside Capture
132.53%
Downside Capture
74.95%

Return for Risk

Risk / Return Rank

RMD ranks 40 for risk / return — below 40% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


RMD Risk / Return Rank: 4040
Overall Rank
RMD Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
RMD Sortino Ratio Rank: 3535
Sortino Ratio Rank
RMD Omega Ratio Rank: 3434
Omega Ratio Rank
RMD Calmar Ratio Rank: 4444
Calmar Ratio Rank
RMD Martin Ratio Rank: 4444
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for ResMed Inc. (RMD) and compare them to a chosen benchmark (S&P 500 Index).


RMDBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.05

0.90

-0.85

Sortino ratio

Return per unit of downside risk

0.26

1.39

-1.13

Omega ratio

Gain probability vs. loss probability

1.03

1.21

-0.18

Calmar ratio

Return relative to maximum drawdown

0.12

1.40

-1.28

Martin ratio

Return relative to average drawdown

0.28

6.61

-6.32

Explore RMD risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

ResMed Inc. provided a 1.04% dividend yield over the last twelve months, with an annual payout of $2.33 per share. The company has been increasing its dividends for 13 consecutive years.


1.00%1.50%2.00%$0.00$0.50$1.00$1.50$2.0020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$2.33$2.26$2.02$1.84$1.72$1.62$1.56$1.52$1.44$1.36$1.26$1.16

Dividend yield

1.04%0.94%0.88%1.07%0.83%0.62%0.73%0.98%1.26%1.61%2.03%2.16%

Monthly Dividends

The table displays the monthly dividend distributions for ResMed Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.60$0.00$0.60
2025$0.00$0.53$0.00$0.00$0.53$0.00$0.00$0.60$0.00$0.00$0.60$0.00$2.26
2024$0.00$0.48$0.00$0.00$0.48$0.00$0.00$0.53$0.00$0.00$0.53$0.00$2.02
2023$0.00$0.44$0.00$0.00$0.44$0.00$0.00$0.48$0.00$0.00$0.48$0.00$1.84
2022$0.00$0.42$0.00$0.00$0.42$0.00$0.00$0.44$0.00$0.00$0.44$0.00$1.72
2021$0.00$0.39$0.00$0.00$0.39$0.00$0.00$0.42$0.00$0.00$0.42$0.00$1.62

Dividend Yield & Payout


Dividend Yield

ResMed Inc. has a dividend yield of 1.04%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.

Payout Ratio

ResMed Inc. has a payout ratio of 22.25%, which is below the market average. This means ResMed Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the ResMed Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ResMed Inc. was 61.61%, occurring on Apr 8, 1999. Recovery took 200 trading sessions.

The current ResMed Inc. drawdown is 23.22%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-61.61%Jan 26, 199951Apr 8, 1999200Jan 21, 2000251
-60%Dec 4, 2001127Jun 6, 2002726Apr 25, 2005853
-53.99%Sep 9, 2021538Oct 27, 2023441Aug 4, 2025979
-45.02%Feb 5, 2007437Oct 27, 2008321Feb 5, 2010758
-44.48%Mar 23, 200046May 26, 2000146Dec 22, 2000192

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of ResMed Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how ResMed Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for RMD, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, RMD has a P/E ratio of 14.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for RMD compared to other companies in the Medical Instruments & Supplies industry. RMD currently has a PEG ratio of 0.5. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for RMD relative to other companies in the Medical Instruments & Supplies industry. Currently, RMD has a P/S ratio of 4.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items